Articles by Jill Wechsler - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jill Wechsler

Global Health Challenges Spur Vaccine Development

Manufacturers fund research and reduce prices to tackle diseases around the world.
Oct 1, 2011

Manufacturers fund research and reduce prices to tackle diseases around the world.

Manufacturers and FDA Gear Up for User-Fee Action

PDUFA renewal legislation sets stage for new policies affecting revenue, research, and oversight.
Sep 1, 2011

PDUFA renewal legislation sets stage for new policies affecting revenue, research, and oversight.

FDA Maps Strategy to Counter Supply-Chain Threats

Rising imports, overseas production spur collaboration and realignment of enforcement activities.
Aug 1, 2011

Rising imports, overseas production spur collaboration and realignment of enforcement activities.

FDA and Manufacturers Ponder Biosimilars Pathway

Follow-on versions of complex biologics require extensive expertise.
Jul 1, 2011

Follow-on versions of complex biologics require extensive expertise.

Safety Concerns and Shortages Challenge Pharma Manufacturing

Industry struggles to curb drug abuse, diversion, and disruptions in supply to ensure access to quality products.
Jun 1, 2011

Industry struggles to curb drug abuse, diversion, and disruptions in supply to ensure access to quality products.

Filling the Pharma Pipeline

FDA, NIH, and industry seek new strategies to spur drug development and promote access to therapies.
May 1, 2011

FDA, NIH, and industry seek new strategies to spur drug development and promote access to therapies.

Health-Reform Controversies

Health-reform controversies pose new challenges.
Apr 1, 2011

Courts and Congress seek to reshape policies and programs affecting drug costs and access.

Drug Safety and Shortages Challenge Manufacturers

As drug shortages make headlines, FDA tets the Sentinel safety system and its effect on healthcare
Mar 1, 2011

As drug shortages make headlines, FDA tests the Sentinel safety system and its effect on healthcare.

Congress to Scrutinize FDA Rules, Research Policies

FDA prepares for top-level changes while promoting transparency and product safety
Feb 1, 2011

FDA prepares for top-level changes while promoting transparency and product safety

ADVERTISEMENT

ADVERTISEMENT

Click here